DAKT
Daktronics, Inc.
DAKT's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over DAKT overall, supported by stronger valuation and stronger fundamentals.
DAKT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Strong |
DAKT's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
DAKT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $19.50 | — |
| Cheap | 17x | $16.85 | -14% |
| Current | 20x | $19.50 | — |
| Fair | 38x | $37.44 | +92% |
| Expensive | 193x | $191 | +879% |
Historical ranges are pointers, not guarantees.
DAKT's PE is in its cheap range at 20x. If earnings grow as analysts expect, today's price would be 13x next year's earnings.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over DAKT in the historical PE scenario, which offers more potential upside but is not a forecast.
DAKT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
DAKT has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
DAKT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.49 | +51% |
| Q3 2026 | $0.99 | +$1.00 |
| Q2 2026 | $0.92 | +$1.37 |
| Q1 2026 | $0.54 | +$0.74 |
| Q4 2025 | $0.12 | -52% |
| Q3 2025 | -$0.01 | -113% |
| Q2 2025 | -$0.45 | -174% |
| Q1 2025 | -$0.20 | -119% |
| Q4 2024 | $0.25 | -76% |
DAKT has returned to profit: it earned $0.99 per share over the past year, after losing money the year before.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over DAKT on earnings, with more consistent year-over-year improvement.
DAKT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $234.6M | +7.1% |
| Q2 2026 | $208.6M | +21% |
| Q1 2026 | $181.9M | +22% |
| Q4 2025 | $229.3M | +10% |
| Q3 2025 | $219M | -3.1% |
| Q2 2025 | $172.6M | -20% |
| Q1 2025 | $149.5M | -12% |
| Q4 2024 | $208.3M | +4.5% |
DAKT's revenue has grown year over year for four quarters in a row: $235M last quarter, up 7.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | 0 points |
| Q2 2026 | 6.8% | +7.8 points |
| Q1 2026 | 1.1% | +3.5 points |
| Q4 2025 | 9.4% | +1.8 points |
| Q3 2025 | 11% | +0.6 points |
| Q2 2025 | -1% | -10 points |
| Q1 2025 | -2.4% | -7.2 points |
| Q4 2024 | 7.6% | -2.2 points |
DAKT's operating margin was 11% last quarter, about level with the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over DAKT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over DAKT on profitability, with a higher operating margin.
DAKT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $27.3M | +25% |
| Q2 2026 | -$9.6M | -153% |
| Q1 2026 | $8.1M | +3.4% |
| Q4 2025 | $14M | -63% |
| Q3 2025 | $21.8M | +51% |
| Q2 2025 | $18M | +196% |
| Q1 2025 | $7.8M | +54% |
| Q4 2024 | $38M | +86% |
DAKT still generates free cash flow, though less than at its 2024 peak: $40M over the past year.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over DAKT on cash flow, with more consistent year-over-year improvement.
DAKT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -481K shares |
| 1 year | -1.7% | -835K shares |
| 3 years | +5.9% | +2.7M shares |
| 5 years | +7.7% | +3.5M shares |
| Available history | +8% | +3.6M shares |
DAKT has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.4M |
| Q2 2026 | $2.8M |
| Q1 2026 | $10.6M |
| Q4 2025 | $1.6M |
| Q3 2025 | $10.7M |
| Q2 2025 | $20.5M |
| Q2 2024 | — |
| Q2 2023 | — |
DAKT spent $19M buying back its own shares over the past year.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
DAKT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.8x | Net Cash |
| Q2 2026 | -1.5x | Net Cash |
| Q1 2026 | -2.1x | Net Cash |
| Q4 2025 | -2.4x | Net Cash |
| Q3 2025 | -2.4x | Net Cash |
| Q2 2025 | -2.2x | Net Cash |
| Q1 2025 | -1.2x | Net Cash |
| Q4 2024 | -0.8x | Net Cash |
DAKT has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
DAKT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.9 | Neutral |
| Stochastic | 46.5 | Neutral |
DAKT's weekly RSI is 51 (neutral) and its Stochastic is 46 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
DAKT PE vs Technology Sector
| Metric | DAKT | Sector median | Relative |
|---|---|---|---|
| PE | 20x | 28x | 29% below |
| PE % | 20 | 35 | 15 pts below |
DAKT has the edge over NVDA on valuation relative to its sector.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
DAKT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.7 | 4.3% above |
| 20 week MA | $19.1 | 1.9% above |
| 50 week MA | $20.2 | 3.5% below |
| 100 week MA | $18.3 | 6.8% above |
| 200 week MA | $13.8 | 41% above |
DAKT has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
DAKT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.01 | $4.80 | -20% |
| 2021 | $4.80 | $5.08 | +5.8% |
| 2022 | $5.08 | $2.97 | -42% |
| 2023 | $2.97 | $8.48 | +186% |
| 2024 | $8.48 | $17.0 | +100% |
| 2025 | $17.0 | $18.6 | +9.4% |
| 2026 YTD | $18.6 | $19.5 | +5.1% |
DAKT has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.